DHA screening starts at 40: what Dubai patients should do after a benign breast lump

For patients in Dubai, a breast lump previously described as benign still needs documented follow-up, because the practical risk is delay, missed imaging, or a biopsy that comes too late.

The Gulf News profile published on 5 October 2026 is useful for patients because it points to a common UAE problem: a reassuring result can become a reason to stop checking. Dubai patients should treat any new breast pain, lump, nipple discharge, skin change, or armpit swelling as a same-week appointment issue with a licensed doctor, then keep every ultrasound, mammogram, biopsy report and image file in one folder.

What Dubai patients should do first

The regulator for Dubai is the Dubai Health Authority (DHA). DHA's Periodic Health Screening Guideline, issued on 11 March 2024 and effective from 11 May 2024, advises women aged 40 years and above to have a mammogram every 2 years. Earlier screening may be advised for a family history of breast cancer or a known inherited mutation.

A new lump is different from routine screening. Screening is for people without symptoms. A lump needs diagnostic work-up, usually a clinical breast exam, targeted breast ultrasound, mammography when age-appropriate, and biopsy if imaging is suspicious. The patient should ask the doctor to record the BI-RADS category, because that score guides whether follow-up, short-interval imaging, or biopsy is needed.

• Ask for the written radiology report and image files before leaving the facility.
• Confirm whether the report says screening, diagnostic mammogram, ultrasound, MRI, fine needle aspiration, or core biopsy.
• If biopsy is recommended, ask the facility to submit insurance pre-authorisation the same day.
• If the result is benign, ask for the next follow-up date in writing.

Costs and insurance checks

Self-pay prices in Dubai vary by facility and whether consultation is included. Current advertised private-sector prices show a practical range: AED 375 for a mammogram, AED 350 for breast ultrasound, and AED 725 for both at Mediclinic Middle East. A separate Dubai package at Clemenceau Medical Center lists mammogram, breast ultrasound and specialist consultation at AED 750, and an ultrasound-guided breast biopsy at AED 4,800.

These are advertised prices, not tariff guarantees. Patients should call the facility and ask for the cash price, the insurer network status, the CPT or internal billing code, and whether pathology is billed separately. For insured patients, the financial risk usually sits in four places: network restrictions, pre-authorisation delays, annual limits, and exclusions for screening when there is no medical indication.

Dubai residents should also check whether their insurer treats the appointment as preventive screening or diagnostic care. A symptomatic lump should be documented as diagnostic assessment. That wording matters when a claim is reviewed.

Abu Dhabi and northern emirates

In Abu Dhabi and Al Ain, the relevant regulator is the Department of Health Abu Dhabi (DOH). Abu Dhabi Public Health Centre says breast screening services are available through the IFHAS comprehensive screening programme for Thiqa cardholders, with mammography every 2 years. DOH's breast cancer screening standard also sets higher-risk pathways, including annual mammography and annual MRI for some women with 20-25% lifetime risk or known high-risk mutations.

In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, the national regulator is the Ministry of Health and Prevention (MOHAP). MOHAP's national breast cancer screening and diagnosis guidance uses the same basic rule for average-risk women: start mammography at 40, then repeat at the recommended interval. Patients in the northern emirates should verify whether the provider is MOHAP-licensed and whether imaging, biopsy and oncology referral are available in the same network.

The next step is simple and time-sensitive. A patient with a breast change in Dubai should book a breast-focused consultation, bring prior images, ask for a written BI-RADS score, and confirm insurance approval before any biopsy. Patients comparing providers can use the UAE Open Healthcare Directory to find licensed oncology and breast-care providers across Dubai, Abu Dhabi and the northern emirates.